Table 1. Summary of available mouse models of endometriosis, demonstrating the presence of fibrotic markers.
Experimental model | Induction method | Fibrotic genes involved | Mechanism | Inflammatory response | References |
---|---|---|---|---|---|
BALB/c | Surgical method | TGF-β, COL1A1 and COL3A1, α-SMA | Platelet activation contributing to EMT, FMT, and SMM | Activation of TGF-β1 | 93 |
Swiss nude mice | Transplantation of human endometrial tissues | α-SMA, COL1A1, fibronectin, CTGF | Cell proliferation and migration
Enhanced collagen gel contraction Wnt/β-catenin signaling |
Wnt/β-catenin interaction with TGF-β1 | 94 |
C57BL/6 | Transplanting shed endometrial tissue from female donor mice into recipient mice | Fibronectin, COL1A1 | Shed endometrial tissue as a key source of pro-inflammatory mediators thereby driving fibrosis | IL-6, TNFα, CCL2 and CCL5 | 76 |
BALB/c | Intraperitoneal injection of uterine fragments from donor mice | α-SMA, FSP-1/S100A4, Desmin, vimentin | EMT, FMT, SMM, MMT, EndoMT | SP and CGRP sensory nerve-derived inflammatory mediators | 95 |
BABL/c nude mice | Transplanting endometrial tissue into the peritoneal cavity of mice | Fibronectin, ColA1, α-SMA, and CTGF | Paracrine signaling of eMSCs | Thrombospondin 4 | 96 |
Swiss nude mice | Implanting pieces of autologous endometrial tissue into the peritoneal cavity of the mice | A-SMA, Col-I, FN and CTGF | TGF-β signaling | TNF-α, IL-6 | 97 |
BALB/c | Intraperitoneal injection of human eutopic endometrial tissue | Collagen I, α-SMA, and CTGF | CTGF signaling | - | 98 |
C57BL/6 | Heterotransplantation with immortalized human endometrial cells | α-SMA, COL1A-I, FN and CTGF | mTOR signaling | - | 99 |
C57BL/6 | Donor endometrial tissue fragments transplanted into the recipient | α-SMA, COL1AI, TGF-β1 | Platelet activation and fibrosis | CD41 | 100 |
Athymic nude mice | Subcutaneous injection of proliferative endometrial fragments | α-SMA, COL1A1, CTGF, FN | Wnt/β-catenin pathway | TGF-β1 | 101 |
Alpha-smooth muscle actin (α-SMA), connective tissue growth factor (CTGF), fibronectin (FN), transforming growth factor beta (TGF-β), COL1A1 and A3 (collagen types 1 and 3), epithelial-to-mesenchymal transition (EMT), fibroblast-to-myofibroblast transdifferentiation (FMT), smooth muscle metaplasia (SMM), tumor necrosis factor α (TNFα), monocyte chemoattractant protein chemokine ligands 2 and 5, fibroblast-specific protein 1 (FSP1), S100 calcium-binding protein A4 (S100A4), TNF-α (tumor necrosis factor-alpha) and IL-6 (interleukin-6), the mesothelial-mesenchymal transition (MMT), the endothelial-mesenchymal transition (EndoMT), endosome-derived mesenchymal stem cells (eMSCs), and mammalian target of rapamycin (mTOR).